Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells

PLoS ONE

Volumn 12, Issue 10, 2017, Pages

  Thirunavukkarasan, Madhumathi ^a   Wang, Chao ^a,b   Rao, Angad ^a   Hind, Tatsuma ^a,c   Teo, Yuan Ru ^a   Siddiquee, Abrar Al Mahmood ^a   Goghari, Mohamed Ally Ibrahim ^a   Kumar, Alan Prem ^a,b,d,e,f   Herr, Deron R ^a,g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d CURTIN UNIVERSITY   (Australia)

^e Cancer Institute   (Singapore)

^f UNIVERSITY OF NORTH TEXAS   (United States)

^g SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN FFAR2; PROTEIN FFAR3; SHORT CHAIN FATTY ACID; SHORT CHAIN FATTY ACID RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; VOLATILE FATTY ACID;

ACTIN POLYMERIZATION; ARTICLE; CANCER GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; HIPPO-YAP SIGNALING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAPK SIGNALING; MCF-7 CELL LINE; MDA-MB-231 CELL LINE; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; BREAST TUMOR; FEMALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; FATTY ACIDS, VOLATILE; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHORYLATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85031714679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0186334     Document Type: Article

References (56)

1. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nature reviews Cancer. 2002; 2(8):563–72. Epub 2002/08/03. https://doi.org/10.1038/nrc865 PMID: 12154349.
2. Fidler IJ. The pathogenesis of cancer metastasis: the’seed and soil’ hypothesis revisited. Nature reviews Cancer. 2003; 3(6):453–8. Epub 2003/06/05. https://doi.org/10.1038/nrc1098 PMID: 12778135.
3. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006; 127(4):679–95. Epub 2006/11/18. https://doi.org/10.1016/j.cell.2006.11.001 PMID: 17110329.
4. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. The Journal of clinical investigation. 2009; 119(6):1429–37. Epub 2009/06/03. https://doi.org/10.1172/JCI36183 PMID: 19487819; PubMed Central PMCID: PMCPMC2689132.
5. Chao YL, Shepard CR, Wells A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Molecular cancer. 2010; 9:179. Epub 2010/07/09. https://doi.org/10.1186/ 1476-4598-9-179 PMID: 20609236; PubMed Central PMCID: PMCPMC2907333.
6. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. The Journal of clinical investigation. 2009; 119(6):1420–8. Epub 2009/06/03. https://doi.org/10.1172/JCI39104 PMID: 19487818; PubMed Central PMCID: PMCPMC2689101.
7. Niessen K, Fu Y, Chang L, Hoodless PA, McFadden D, Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. The Journal of cell biology. 2008; 182(2):315–25. Epub 2008/07/30. https://doi.org/10.1083/jcb.200710067 PMID: 18663143; PubMed Central PMCID: PMCPMC2483533.
8. Medici D, Hay ED, Olsen BR. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Molecular biology of the cell. 2008; 19(11):4875–87. Epub 2008/09/19. https://doi.org/10.1091/mbc.E08-05-0506 PMID: 18799618; PubMed Central PMCID: PMCPMC2575183.
9. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nature reviews Cancer. 2002; 2 (6):442–54. Epub 2002/08/22. https://doi.org/10.1038/nrc822 PMID: 12189386.
10. Jechlinger M, Grunert S, Beug H. Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. Journal of mammary gland biology and neoplasia. 2002; 7(4):415–32. Epub 2003/07/29. PMID: 12882526.
11. Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. Journal of cellular biochemistry. 2007; 101(4):816–29. Epub 2007/01/24. https://doi.org/10.1002/jcb.21215 PMID: 17243120.
12. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nature reviews Cancer. 2007; 7 (2):79–94. Epub 2007/01/26. https://doi.org/10.1038/nrc2069 PMID: 17251915.
13. Balkwill F. Cancer and the chemokine network. Nature reviews Cancer. 2004; 4(7):540–50. Epub 2004/ 07/02. https://doi.org/10.1038/nrc1388 PMID: 15229479.
14. Kochetkova M, Kumar S, McColl SR. Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell death and differentiation. 2009; 16(5):664–73. Epub 2009/01/13. https://doi.org/10.1038/cdd.2008.190 PMID: 19136936.
15. Pyne NJ, McNaughton M, Boomkamp S, MacRitchie N, Evangelisti C, Martelli AM, et al. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation. Advances in biological regulation. 2016; 60:151–9. Epub 2015/10/03. https://doi.org/10.1016/j.jbior.2015.09.001 PMID: 26429117.
16. Pyne NJ, Pyne S. Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells. Molecules. 2017; 22(3). https://doi.org/10.3390/molecules22030344 PMID: 28241498.
17. Patmanathan SN, Wang W, Yap LF, Herr DR, Paterson IC. Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. Cell Signal. 2017; 34:66–75. https://doi.org/10.1016/j.cellsig.2017.03.002PMID: 28302566.
18. Houben AJ, Moolenaar WH. Autotaxin and LPA receptor signaling in cancer. Cancer metastasis reviews. 2011; 30(3–4):557–65. Epub 2011/10/18. https://doi.org/10.1007/s10555-011-9319-7 PMID: 22002750.
19. Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins & other lipid mediators. 2010; 91(3–4):130–8. Epub 2010/03/25. https://doi.org/10.1016/j.prostaglandins.2009.02.002 PMID: 20331961; PubMed Central PMCID: PMCPMC2845529.
20. van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar WH. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 1989; 59 (1):45–54. Epub 1989/10/06. PMID: 2551506.
21. Herr DR. Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers. International review of cell and molecular biology. 2012; 297:45–81. Epub 2012/05/ 23. https://doi.org/10.1016/B978-0-12-394308-8.00002-9 PMID: 22608557.
22. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. The Journal of biological chemistry. 2003; 278(13):11303–11. Epub 2002/12/24. https://doi.org/10.1074/jbc.M211495200PMID: 12496284.
23. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of biological chemistry. 2003; 278(13):11312–9. Epub 2002/12/24. https://doi.org/10.1074/jbc.M211609200 PMID: 12496283.
24. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochemical and biophysical research communications. 2003; 303(4):1047–52. Epub 2003/04/10. PMID: 12684041.
25. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. The Journal of biological chemistry. 2003; 278(28):25481–9. Epub 2003/04/25. https://doi.org/10.1074/jbc. M301403200 PMID: 12711604.
26. Bindels LB, Dewulf EM, Delzenne NM. GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends in pharmacological sciences. 2013; 34(4):226–32. Epub 2013/03/16. https://doi.org/10.1016/j.tips.2013.02.002 PMID: 23489932.
27. Zaibi MS, Stocker CJ, O’Dowd J, Davies A, Bellahcene M, Cawthorne MA, et al. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS letters. 2010; 584(11):2381–6. Epub 2010/04/20. https://doi.org/10.1016/j.febslet.2010.04.027 PMID: 20399779.
28. Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 2005; 1 (4):245–58. Epub 2005/08/02. S1550-4131(05)00086-0 [pii] https://doi.org/10.1016/j.cmet.2005.03.007 PMID: 16054069.
29. Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008; 57(9):2280–7. Epub 2008/06/04. https://doi.org/10.2337/db08-0307 PMID: 18519800; PubMed Central PMCID: PMCPMC2518478.
30. Tang Y, Chen Y, Jiang H, Robbins GT, Nie D. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. International journal of cancer. 2011; 128(4):847–56. Epub 2010/10/28. https://doi.org/10.1002/ijc.25638 PMID: 20979106.
31. Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, Martin JC, et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. British journal of cancer. 2012; 107(8):1337–44. Epub 2012/09/15. https://doi.org/10.1038/bjc.2012.409 PMID: 22976799; PubMed Central PMCID: PMCPMC3494429.
32. Tang Y, Chen Y, Jiang H, Nie D. The role of short-chain fatty acids in orchestrating two types of programmed cell death in colon cancer. Autophagy. 2011; 7(2):235–7. PMID: 21160278.
33. Tang Y, Chen Y, Jiang H, Nie D. Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death. Cell death and differentiation. 2011; 18 (4):602–18. https://doi.org/10.1038/cdd.2010.117 PMID: 20930850; PubMed Central PMCID: PMCPMC3020988.
34. Tang J, Yan H, Zhuang S. Histone deacetylases as targets for treatment of multiple diseases. Clinical Science. 2013; 124(11):651–62. https://doi.org/10.1042/CS20120504 PMID: 23414309
35. Herr DR, Lee CW, Wang W, Ware A, Rivera R, Chun J. Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development. The Journal of biological chemistry. 2013; 288(41):29882–9. Epub 2013/09/05. https://doi.org/10.1074/jbc.M113.510099 PMID: 24003216; PubMed Central PMCID: PMCPMC3795286.
36. Harris GL, Creason MB, Brulte GB, Herr DR. In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody. PloS one. 2012; 7(4):e35129. Epub 2012/ 04/13. https://doi.org/10.1371/journal.pone.0035129 PMID: 22496900; PubMed Central PMCID: PMCPMC3320623.
37. Rao A, Herr DR. G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells. Biochim Biophys Acta. 2017; 1864(7):1318–27. https://doi.org/10.1016/j.bbamcr.2017.05.001 PMID: 28476646.
38. Godfrey J, Jeanguenin L, Castro N, Olney JJ, Dudley J, Pipkin J, et al. Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats. PloS one. 2015; 10(9):e0139012. Epub 2015/09/26. https://doi.org/10.1371/journal.pone.0139012 PMID: 26405804; PubMed Central PMCID: PMCPMC4583526.
39. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif). 2001; 25(4):402–8. Epub 2002/02/16. https://doi.org/10.1006/meth.2001.1262 PMID: 11846609.
40. Inoue A, Ishiguro J, Kitamura H, Arima N, Okutani M, Shuto A, et al. TGFalpha shedding assay: an accurate and versatile method for detecting GPCR activation. Nature methods. 2012; 9(10):1021–9. Epub 2012/09/18. https://doi.org/10.1038/nmeth.2172 PMID: 22983457.
41. Herr DR, Reolo MJY, Peh YX, Wang W, Lee CW, Rivera R, et al. Sphingosine 1-phosphate receptor 2 (S1P(2)) attenuates reactive oxygen species formation and inhibits cell death: implications for otopro-tective therapy. Scientific Reports. 2016; 6. https://doi.org/10.1038/srep24541 PMID: 27080739; PubMed Central PMCID: PMCPMC4832229.
42. Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014; 6(10):1279–93. https://doi.org/10.15252/emmm.201404208 PMID: 25214461; PubMed Central PMCID: PMCPMC4287932.
43. Wu J, Zhou Z, Hu Y, Dong S. Butyrate-induced GPR41 Activation Inhibits Histone Acetylation and Cell Growth. Journal of Genetics and Genomics. 2012; 39(8):375–84. http://dx.doi.org/10.1016/j.jgg.2012.05.008. https://doi.org/10.1016/j.jgg.2012.05.008 PMID: 22884094
44. Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal immunology. 2013; 6(3):498–510. Epub 2012/09/20. https://doi.org/10.1038/mi.2012.89 PMID: 22990622; PubMed Central PMCID: PMCPMC3629381.
45. Haynes J, Srivastava J, Madson N, Wittmann T, Barber DL. Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Molecular biology of the cell. 2011; 22(24):4750–64. Epub 2011/10/28. https://doi.org/10.1091/mbc.E11-02-0119 PMID: 22031288; PubMed Central PMCID: PMCPMC3237619.
46. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012; 150(4):780–91. Epub 2012/08/07. https://doi.org/10.1016/j.cell.2012.06.037 PMID: 22863277; PubMed Central PMCID: PMCPMC3433174.
47. Dong J, Feldmann G, Huang J, Wu S, Zhang NZ, 2007 #389}, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007; 130(6):1120–33. Epub 2007/ 09/25. https://doi.org/10.1016/j.cell.2007.07.019 PMID: 17889654; PubMed Central PMCID: PMCPMC2666353.
48. Seljeset S, Siehler S. Receptor-specific regulation of ERK1/2 activation by members of the "free fatty acid receptor" family. Journal of receptor and signal transduction research. 2012; 32(4):196–201. Epub 2012/06/21. https://doi.org/10.3109/10799893.2012.692118 PMID: 22712802.
49. Yonezawa T, Kobayashi Y, Obara Y. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell Signal. 2007; 19(1):185–93. Epub 2006/08/05. https://doi.org/10.1016/j.cellsig.2006.06.004 PMID: 16887331.
50. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcrip-tomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012; 486(7403):346–52. https://doi.org/10.1038/nature10983 PMID: 22522925; PubMed Central PMCID: PMCPMC3440846.
51. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483 (7391):603–7. https://doi.org/10.1038/nature11003 PMID: 22460905; PubMed Central PMCID: PMCPMC3320027.
52. Uhlen M, Zhang C, Lee S, Sjostedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. Science. 2017; 357(6352). https://doi.org/10.1126/science.aan2507 PMID: 28818916.
53. Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Science Signaling. 2014; 7(344):re8–re. https://doi.org/10.1126/scisignal.2005189 PMID: 25249658
54. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature cell biology. 2000; 2(2):84–9. Epub 2000/02/03. https://doi.org/10.1038/35000034 PMID: 10655587.
55. Kim S, Kim YM, Kwak YS. A novel therapeutic target, GPR43; where it stands in drug discovery. Archives of pharmacal research. 2012; 35(9):1505–9. Epub 2012/10/12. https://doi.org/10.1007/ s12272-012-0900-6 PMID: 23054706.
56. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nature reviews Molecular cell biology. 2014; 15(3):178–96. Epub 2014/02/22. https://doi.org/10.1038/nrm3758PMID: 24556840; PubMed Central PMCID: PMCPMC4240281.